---
title: Hereditary Cancer Testing - New Oncology Menu
description: Identify hereditary cancer risks early, with support from Ambry Genetics at every step.
image: https://info.ambrygenetics.com/hubfs/Banner1_1.jpg
---

[![Ambry_logo_Tempus_RGB](https://info.ambrygenetics.com/hs-fs/hubfs/Ambry_logo_Tempus_RGB.png?width=275&height=52&name=Ambry_logo_Tempus_RGB.png "Ambry_logo_Tempus_RGB")](https://www.ambrygen.com/)

[![Ambry_ATempusCompany_Logo_Reversed](https://info.ambrygenetics.com/hs-fs/hubfs/Ambry_ATempusCompany_Logo_Reversed.png?width=720&height=140&name=Ambry_ATempusCompany_Logo_Reversed.png "Ambry_ATempusCompany_Logo_Reversed")](https://www.ambrygen.com/)

Now Available

# **Introducing our Enhanced Hereditary Cancer Testing Portfolio**

 

###### **INTERESTED IN LEARNING MORE ABOUT HEREDITARY CANCER TESTING WITH AMBRY?**

Provide your information, and we’ll reach out to you with more information.

## Maximize Insights and Minimize Uncertainty with our Enhanced Hereditary Cancer Testing Portfolio

### The evidence-informed, flexible tests you need to find answers for your patients.

Our [enhanced menu](https://blog.ambrygen.com/ambry/post/361/2024-hereditary-cancer-testing-menu-update) offers a flexible approach to genetic testing, informed by guidelines and scientific evidence. This comprehensive portfolio will deliver the clinical insights you need, paired with the exceptional support and patient access you have come to expect from Ambry.

#### Key Updates

Multiple tests designed based on consensus management guidelines for maximized clinical utility.

New indications and genes added for more comprehensive genetic assessment.

Enhancements to improve flexibility and ease-of-use, including new addon options and an easier approach to ordering all cancer predisposition genes on the menu.

+RNAinsight®, paired DNA/  
RNA testing, remains available  
for order in combination with  
any genes on the hereditary  
cancer menu.1

![Ongoing Revised Reports](https://info.ambrygenetics.com/hubfs/Ongoing.jpg "Ongoing Revised Reports")

#### Read more...

## [The Evolution of Hereditary Cancer Testing: Why Pan-Cancer Panels Are the Future of Genetic Risk Assessment](https://blog.ambrygen.com/ambry/post/362/the-evolution-of-hereditary-cancer-testing-why-pan-cancer-panels-are-the-future-of-genetic-risk-assessment)

*Elizabeth Chao, MD, FACMG* | *October 17th, 2024*

 

## [Striking the Perfect Balance in Designing Hereditary Cancer Tests: The Ambry Approach](https://blog.ambrygen.com/ambry/post/363/striking-the-perfect-balance-in-designing-hereditary-cancer-tests-the-ambry-approach)

*Jessica Grzybowski, MS, CGC* | *October 31st, 2024*

1. Not available for STAT testing or with BRCAPlus®

![](https://info.ambrygenetics.com/hs-fs/hubfs/form%20logo.png?width=200&height=35&name=form%20logo.png)

© 2026 Ambry Genetics

All rights reserved.

#### Questions? Contact Us.

[info@ambrygen.com](mailto:info@ambrygen.com)  (949) 900-5500